Related Experiment Video

Updated: Jun 14, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Dendritic cell vaccines for cancer immunotherapy

J M Timmerman1, R Levy

  • 1Department of Medicine, Stanford University School of Medicine, California 94305, USA. jtimmer@leland.stanford.edu

Annual Review of Medicine
|March 12, 1999
PubMed

Insights

Dendritic cell (DC) vaccines loaded with tumor antigens show promise for cancer immunotherapy. These vaccines activate T cells to fight tumors, leading to observed anti-tumor immunity and regressions in early clinical trials.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Human tumors express antigens recognized by T cells, offering targets for cancer immunotherapy.
  • Dendritic cells (DCs) are potent antigen-presenting cells crucial for initiating T cell responses.
  • DCs are being explored for therapeutic cancer vaccines due to their immune-stimulating properties.

Purpose of the Study:

  • To evaluate the potential of dendritic cell (DC) vaccination as a cancer immunotherapy.
  • To summarize the application of DCs in therapeutic cancer vaccines and their observed outcomes.

Main Methods:

  • Ex vivo loading of isolated DCs with tumor antigens.
  • Administration of antigen-loaded DCs as a cellular vaccine in preclinical models and human clinical trials.
  • Exploration of in vivo methods for targeting tumor antigens to DCs.

Main Results:

  • DC vaccination induced protective and therapeutic anti-tumor immunity in experimental animals.
  • Pilot clinical trials in non-Hodgkin's lymphoma and melanoma patients showed induction of anti-tumor immune responses.
  • Tumor regressions were observed in patients participating in early DC vaccination trials.

Conclusions:

  • Dendritic cell vaccination is a promising strategy for developing effective cancer immunotherapies.
  • Harnessing the antigen-presenting capabilities of DCs offers a viable approach to cancer treatment.
  • Ongoing trials and in vivo targeting methods aim to further optimize DC-based cancer vaccines.

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...